Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/11780680
Conclusion of this study
Our results suggest CoQ may be safely offered to hypertensive patients as an alternative treatment option.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
 Cardiovascular System |
